Cipher Pharmaceuticals Inc.

TSX:CPH Voorraadrapport

Marktkapitalisatie: CA$374.9m

Cipher Pharmaceuticals Beheer

Beheer criteriumcontroles 2/4

De CEO Cipher Pharmaceuticals is Craig Mull, benoemd in Jul2019, heeft een ambtstermijn van 5.33 jaar. bezit rechtstreeks 3.19% van de aandelen van het bedrijf, ter waarde CA$ 11.97M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 2.5 jaar en 3.5 jaar.

Belangrijke informatie

Craig Mull

Algemeen directeur

US$1.0m

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO5.3yrs
Eigendom CEO3.2%
Management gemiddelde ambtstermijn2.5yrs
Gemiddelde ambtstermijn bestuur3.5yrs

Recente managementupdates

Recent updates

Cipher Pharmaceuticals' (TSE:CPH) Anemic Earnings Might Be Worse Than You Think

Nov 14
Cipher Pharmaceuticals' (TSE:CPH) Anemic Earnings Might Be Worse Than You Think

With A 29% Price Drop For Cipher Pharmaceuticals Inc. (TSE:CPH) You'll Still Get What You Pay For

Nov 12
With A 29% Price Drop For Cipher Pharmaceuticals Inc. (TSE:CPH) You'll Still Get What You Pay For

Cipher Pharmaceuticals Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Nov 09
Cipher Pharmaceuticals Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

There's No Escaping Cipher Pharmaceuticals Inc.'s (TSE:CPH) Muted Earnings Despite A 26% Share Price Rise

Mar 23
There's No Escaping Cipher Pharmaceuticals Inc.'s (TSE:CPH) Muted Earnings Despite A 26% Share Price Rise

Weak Statutory Earnings May Not Tell The Whole Story For Cipher Pharmaceuticals (TSE:CPH)

Mar 22
Weak Statutory Earnings May Not Tell The Whole Story For Cipher Pharmaceuticals (TSE:CPH)

Here's Why I Think Cipher Pharmaceuticals (TSE:CPH) Is An Interesting Stock

May 14
Here's Why I Think Cipher Pharmaceuticals (TSE:CPH) Is An Interesting Stock

Analysts Just Published A Bright New Outlook For Cipher Pharmaceuticals Inc.'s (TSE:CPH)

May 18
Analysts Just Published A Bright New Outlook For Cipher Pharmaceuticals Inc.'s (TSE:CPH)

Cipher Pharmaceuticals Inc. Just Missed EPS By 37%: Here's What Analysts Think Will Happen Next

Mar 20
Cipher Pharmaceuticals Inc. Just Missed EPS By 37%: Here's What Analysts Think Will Happen Next

Industry Analysts Just Upgraded Their Cipher Pharmaceuticals Inc. (TSE:CPH) Revenue Forecasts By 12%

Jan 26
Industry Analysts Just Upgraded Their Cipher Pharmaceuticals Inc. (TSE:CPH) Revenue Forecasts By 12%

CEO

Craig Mull

5.3yrs

Tenure

US$1,045,700

Compensatie

Mr. Craig J. Mull has been Chairman of the Board of Directors at Cipher Pharmaceuticals Inc. since June 11, 2019 and its Interim Chief Executive Officer since July 29, 2019, served as its President. Mr. Mu...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Craig Mull
Interim CEO & Chairman of the Board5.3yrsUS$1.05m3.19%
CA$ 12.0m
Bryan Jacobs
Chief Financial Officer2.3yrsUS$391.35k0.020%
CA$ 73.3k
Emilio Presti
Director of Sales & Marketing2.8yrsgeen gegevensgeen gegevens
Hamed Ghanei
Chief Business Officerless than a yeargeen gegevensgeen gegevens

2.5yrs

Gemiddelde duur

Ervaren management: Het managementteam van CPH wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.5 jaar).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Craig Mull
Interim CEO & Chairman of the Board5.7yrsUS$1.05m3.19%
CA$ 12.0m
Harold Wolkin
Lead Independent Director8.3yrsUS$73.49k1.43%
CA$ 5.4m
Douglas Deeth
Independent Director1.4yrsUS$65.57kgeen gegevens
Hubert Walinski
Independent Director1.4yrsUS$62.57kgeen gegevens

3.5yrs

Gemiddelde duur

Ervaren bestuur: De raad van bestuur van CPH wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.5 jaar).